Modifié le 28 February 2023
Dr. Soizic Garaud's will join the LBAI team to lead her postdoctoral project "Immunological variables associated to immune checkpoint inhibitor toxicity in cancer patients".
Modifié le 29 August 2022
New study to investigate the ianalumab monoclonal antibody and its mechanism of efficacy in Sjögren's patients
Modifié le 04 August 2022
Dr. Soizic Garaud is joining the LBAI-UMR1227 as a Postdoctoral Fellow after her project "Immunological variables associated to immune checkpoint inhibitor toxicity in cancer patients" was selected in the framework of the BIENVENÜE programme.
Modifié le 01 June 2022
LBAI will be involved in a new European project after the successful application of the SIGNATURE proposal to the MSCA Doctoral Networks 2021 call.
Modifié le 03 December 2021
HYPERION is joining Biogenouest, an interregional network of technology platforms in life and environmental sciences.
Modifié le 22 November 2021
Dr. Arnaud Uguen has been awarded a grant to lead the project "Combining imaging MAss cytometry with label-free nonlinear and polarized lighT micRoscopIes to decipher the compleX interactions between conjunctive fibers and immune cells in cancer microenvironment: a new approach for biomarker discovery" (MATRIX).
Modifié le 02 July 2021
"High dimensional imaging mass cytometry panel to visualize the tumor immune microenvironment contexture"
Modifié le 25 June 2021
La start-up brestoise KALSIOM boucle son premier tour de financement de 2 millions € auprès de GO CAPITAL, d'Advent France Biotechnology et de la SATT Ouest Valorisation pour le développement de candidats médicaments "First in Class" en immunothérapie.